

250
Correspondencia a:
Dra. Gloria Valdés S.
Email:
gvaldesst@gmail.comuse of insulin pump therapy in type 1 diabetes. Diabetes
Care 2002; 25: 593-8.
23.- Sofaer N. Reciprocity-based reasons for benefiting
research participants: Most fail, the most plausible is
problematic. Bioethics 2014; 28: 456-71.
24.- Mieres C. Las grietas de la Ley Ricarte Soto. Portafo-
lio Salud. Junio 2015; 30-5.
25.- WHO International Clinical Trials Registry Platform
(ICTRP). Disponible en
www.who.int/ictrp/network/ primary/en/index.htmlG. López S. et al.
Rev Chil Enferm Respir 2016; 32: 244-250